Uncategorized

Companies are relying on artificial intelligence–powered applicant tracking systems to keep up the evolving recruitment demands. Here is how.

Congressional legislation seeks to “equalize” the negotiating period between biologics and small molecules under the Inflation Reduction Act’s Drug Price Negotiation Program.

Elevance joins a growing list of insurers expanding their weight management offerings amid soaring demand for GLP-1 drugs.

The Pennsylvania-based hospital operator grew revenue 7% in 2023 despite operational challenges, including high labor costs and strained payer relations. 

Regulators are reportedly looking into the massive healthcare conglomerate’s potential anticompetitive effects, including the relationship between its health insurer UnitedHealthcare and physician network Optum.

The new device is meant to compete with systems offered by Boston Scientific and Abbott that address blood clot risk in atrial fibrillation.

Burnout and turnover remain high among overwhelmed and under-resourced nurse leaders, according to a study from AMN Healthcare.

The agency has seen reports the implants can move out of position and break through the skin.

Plus, last week Richard Gonzalez announced his retirement from AbbVie, PhRMA appointed Gilead’s O’Day to chair its board and Joseph Papa became president and CEO of Emergent.

The company is yet to name Hickey’s replacement but plans to have a successor in place before the executive retires.